Skip to main content

Day: February 23, 2021

Premier Health Reports a 297% Revenue Increase for Its First Quarter of 2021

MONTRÉAL, Feb. 23, 2021 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech company, announces it has filed its Condensed Interim Consolidated Financial Statements and MD&A for its first quarter ended December 31, 2020.SummaryThe Corporation had revenues of $13.4M for the 3 months period (297% increase from $3.4M for Q1-2020) attributable to the consolidation of the Code Bleu acquisition, and organic growth from all business units.The increase in the average gross margin to 28.5% (26.2% for Q1-2020) resulted from a more efficient geographical distribution of services rendered.The EBITDA(1) increased to $1.3M (512% increase from $215,545 for Q1-2020).Net income was $715,645 compared to $136,493 for the same period in 2020.The Corporation completed a $7,486,500 bought...

Continue reading

Newtek Business Services Corp. Declares First Quarter 2021 Dividend of $0.50 per Share

BOCA RATON, Fla., Feb. 23, 2021 (GLOBE NEWSWIRE) — Newtek Business Services Corp., (NASDAQ: NEWT), an internally managed business development company (“BDC”), today announced that its Board of Directors declared a first quarter 2021 cash dividend of $0.501 per share. The first quarter 2021 dividend is payable on March 31, 2021 to shareholders of record as of March 22, 2021. The payment of the first quarter 2021 dividend would represent a 13.6% increase over the first quarter 2020 dividend of $0.44 per share, and a 25% increase over the first quarter 2019 dividend of $0.40 per share.Note regarding Dividend Payments: The Company’s Board of Directors expects to maintain a dividend policy with the objective of making quarterly distributions in an amount that approximates 90 – 100% of the Company’s annual taxable income....

Continue reading

Newtek Business Services Corp.’s CEO, Barry Sloane, Comments on the Declaration of Newtek’s First Quarter 2021 Dividend of $0.50 per Share

BOCA RATON, Fla., Feb. 23, 2021 (GLOBE NEWSWIRE) — Newtek Business Services Corp., (NASDAQ: NEWT), an internally managed business development company (“BDC”), provides Newtek CEO’s, Barry Sloane, comments on the declaration of Newtek’s first quarter 2021 cash dividend of $0.501 per share.Barry Sloane, President, Chairman and CEO commented, “We are pleased to report that our board has declared a first quarter 2021 dividend of $0.50 per share, payable on March 31, 2021 to our shareholders of record as of March 22, 2021. This dividend would represent a 13.6% increase over our first quarter 2020 dividend, which was impacted by the pandemic, and a 25% increase over our first quarter 2019 dividend. We believe our business model leaves us well positioned to continue to capture market opportunities, and we continue to maintain a strong...

Continue reading

NaturalShrimp Signs Letter of Intent to Acquire Aquaculture Assets of Hydrenesis Aquaculture, LLC

– Assets to be Acquired for $12,500,000– Major Financing Announcement Forthcoming from NSIDallas, TX, Feb. 23, 2021 (GLOBE NEWSWIRE) —  via NewMediaWire — NaturalShrimp, Inc., an aquaculture Company, which has developed and patented the first commercially operational Recirculating Aquaculture System (RAS) for shrimp, announced today that it has signed a Letter of Intent (LOI) to acquire the aquaculture assets of Hydrenesis Aquaculture, LLC for $12,500,000, consisting of $5,500,000 in cash and the balance due in NSI common stock. The acquisition is expected to be accretive to earnings in fiscal year 2021.Gerald Easterling, CEO of NaturalShrimp added, “NaturalShrimp has been working with Hydrenesis since 2018 on several solutions for the industry with the team at Hydrenesis. We currently have trials on going in Norway...

Continue reading

Better Choice Company Announces Alex Vournas as Vice President of Supply Chain & Logistics

NEW YORK, Feb. 23, 2021 (GLOBE NEWSWIRE) — Better Choice Company (OTCQX: BTTR) (“Better Choice”) (the “Company”), an animal health and wellness company, announced today the appointment of Alex Vournas as Vice President of Supply Chain & Logistics.Alex Vournas is a highly accomplished Supply Chain professional who most recently was the Director of Supply Chain at Solid Gold Pet LLC, where he oversaw global distribution and logistics and was responsible for managing multiple international and domestic co-manufactures and warehouses, outsourced transportation and ordering logistics. Among many other top accomplishments, Alex was also responsible for managing the logistics related to the company’s significant expansion into Asia, which culminated in a sale of the business to Hong Kong based H&H Group in November 2020. In addition...

Continue reading

SCYNEXIS and Amplity Health Announce Agreement to Support the Anticipated U.S. Commercialization of BrexafemmeTM (Ibrexafungerp) for Vaginal Yeast Infections

Synergistic combination of Amplity’s proven commercial sales capabilities and SCYNEXIS’ internal medical, marketing, and strategic expertise will maximize Brexafemme’s commercial potential while preserving SCYNEXIS’ global rights to the drugAmplity to defer a portion of SCYNEXIS’ commercial launch expenses for the first two years in exchange for a performance-based success feeBrexafemme, the conditionally FDA-approved brand name for ibrexafungerp for vaginal yeast infections, is on track for anticipated June 2021 approval and H2:2021 launchSCYNEXIS in a strong financial position to execute on its plans with a projected cash runway into 2023JERSEY CITY, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) — SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant...

Continue reading

Chinook Therapeutics to Present at 3rd Annual Chronic Kidney Disease Drug Development (CKD3) Summit

Head of Renal Discovery and Translational Medicine, Andrew King, D.V.M., Ph.D., to Present on Atrasentan and Participate in Expert Panel Discussion on Executing Precision Medicine in Clinical TrialsVANCOUVER, British Columbia and SEATTLE, Feb. 23, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Andrew King, D.V.M., Ph.D., Head of Renal Discovery and Translational Medicine, will present on behalf of Chinook at the 3rd Annual Chronic Kidney Disease Drug Development (CKD3) Summit. Dr. King will deliver a presentation titled “Selective ETA receptor antagonist atrasentan for the treatment of primary glomerular diseases” on Thursday, March 4th at 10:00 am EST. Dr. King...

Continue reading

Silo Pharma to Present at Proactive’s One2One Virtual Investor Forum

Englewood Cliffs, NJ, Feb. 23, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders, announced today that Eric Weisblum, Chief Executive Officer will be presenting at Proactive’s One2One Virtual Investor Forum on Tuesday, February 23, at 1 p.m. EST.The Virtual One2One Investor Forum invitation will be sent to Proactive’s estimated 20,000 YouTube subscribers and will be broadcasted internationally.Mr. Weisblum’s presentation will be followed by a Q&A session and it will be published online.For more information or to register for this event please visit https://www.proactiveinvestors.com.au/register/event_details/322About...

Continue reading

Just Energy Group Inc. Reassures Texas Residential Electricity Customers That They Are Protected From Storm-Related Price Surges

Just Energy, Amigo Energy and Tara Energy Residential Customers Will See No Change to Their Electricity Rates on February BillsTORONTO, Feb. 23, 2021 (GLOBE NEWSWIRE) — Just Energy Group Inc. (TSX:JE; NYSE:JE) (“Just Energy” or the “Company”), a retail energy provider specializing in electricity and natural gas commodities, renewable energy options and carbon offsets, today made the following statement to reassure its residential customers in Texas that they are protected from higher energy rates on their February bills as a result of recent extreme weather (the “Weather Event”):“Whether customers know us as Just Energy, Amigo Energy or Tara Energy, we have been a proud part of Texas communities for many years, providing residential energy to hundreds of thousands of customers across the state,” said Scott Gahn, Just Energy’s President...

Continue reading

CUMULUS MEDIA Reports Operating Results for 2020

ATLANTA, Feb. 23, 2021 (GLOBE NEWSWIRE) — Cumulus Media Inc. (NASDAQ: CMLS) (the “Company,” “CUMULUS MEDIA,” “we,” “us,” or “our”) today announced operating results for the three months and year ended December 31, 2020.Mary G. Berner, President and Chief Executive Officer of CUMULUS MEDIA, said, “Given 2020’s extenuating circumstances, I am extremely proud of the Company’s performance and the efforts of the entire Cumulus team to meet the challenges posed by COVID-19. In the face of the pandemic, we maximized revenue performance, materially reduced expenses, generated cash through strong working capital management, and executed highly accretive divestitures that strengthened our balance sheet. As a result of these efforts and with a recovering economy, we believe that we are well-positioned to return our business...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.